Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.6503
+0.0097 (1.51%)
Oct 19, 2026, 4:00 PM EDT - Market closed

RANI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
911324686146322
Market Cap Growth
285.92%188.57%-46.89%-41.09%-54.75%-
Enterprise Value
411415273107273
Last Close Price
0.651.351.373.325.9016.35

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.6580.6544.39--118.62
PB Ratio
1.873.1713.073.381.972.65
P/TBV Ratio
2.323.9922.916.683.966.80

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.4386.3450.21--100.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.108.511.180.41-
Net Debt / Equity Ratio
-1.04-1.090.59-0.72-0.92-0.97
Net Debt / EBITDA Ratio
1.551.21-0.040.281.092.30
Net Debt / FCF Ratio
2.452.41-0.060.351.423.59
Asset Turnover
0.130.030.02--0.03
Quick Ratio
5.234.091.416.1020.4544.49
Current Ratio
5.314.211.506.3720.9645.30
Return on Equity (ROE)
-172.15%-181.98%-391.10%-136.52%-64.78%-54.94%
Return on Assets (ROA)
-53.00%-50.27%-65.57%-49.79%-34.15%-31.68%
Return on Capital Employed (ROCE)
-65.60%-83.40%-296.20%-132.40%-61.50%-42.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-33.13%-22.53%-65.78%-39.54%-20.97%-2.58%
FCF Yield
-22.36%-14.28%-78.37%-61.06%-33.00%-10.16%
Buyback Yield / Dilution
-321.63%-132.26%-11.65%-7.09%-21.93%58.34%
SEC Filings: 10-K · 10-Q